| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-09 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
9e-09 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-08 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.29 |
8e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |